Back to top

Bayer’s MACED Study Targets Heart Risks in Advanced Prostate Cancer Treatments

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The MACED study, or “Major Adverse Cardiovascular Events Among Elderly Patie...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)